Kiyoshi Mori Selected Research

Kiyoshi Mori Research Topics

Disease

22	Neoplasms (Cancer) 03/2022 - 12/2004
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2020 - 02/2002
13	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 07/2002
11	Proteinuria 02/2022 - 07/2002
11	Fibrosis (Cirrhosis) 01/2022 - 05/2002
10	Acute Kidney Injury (Acute Renal Failure) 02/2019 - 12/2004
8	Chronic Renal Insufficiency 04/2018 - 06/2008
7	Infections 10/2022 - 07/2009
7	Albuminuria 01/2018 - 10/2006
6	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2004
6	Neutropenia 08/2016 - 03/2002
5	Heart Failure 10/2022 - 01/2018
5	Hypertrophy 06/2022 - 07/2002
5	Chronic Kidney Failure (Chronic Renal Failure) 02/2022 - 11/2002
5	Kidney Diseases (Kidney Disease) 11/2020 - 07/2006
5	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2005
5	Lung Neoplasms (Lung Cancer) 01/2017 - 12/2004
4	Carcinogenesis 01/2022 - 07/2009
4	Glomerulonephritis 10/2021 - 05/2003
4	Diarrhea 01/2021 - 01/2002
4	Type 2 Diabetes Mellitus (MODY) 04/2018 - 09/2006
4	Inflammation (Inflammations) 01/2018 - 01/2012
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2016 - 01/2002
4	Reperfusion Injury 12/2014 - 12/2004
3	Ischemia 10/2022 - 12/2004
3	Nephrotic Syndrome (Syndrome, Nephrotic) 02/2022 - 09/2005
3	Carcinoma (Carcinomatosis) 10/2019 - 12/2004
3	Peritoneal Fibrosis 01/2018 - 01/2012
3	Obesity 11/2017 - 09/2002
3	Pneumonia (Pneumonitis) 08/2016 - 10/2006
3	Hypoxia (Hypoxemia) 01/2013 - 10/2006
2	Pathologic Constriction (Stenosis) 10/2022 - 06/2021
2	Rectal Neoplasms (Rectal Cancer) 05/2021 - 04/2020
2	Adenocarcinoma 01/2021 - 09/2008
2	Idiopathic Pulmonary Fibrosis 01/2021 - 06/2014
2	Adenocarcinoma of Lung 01/2021 - 09/2008
2	Colitis 01/2021 - 10/2016
2	Thrombotic Microangiopathies 11/2019 - 10/2019
2	Thrombocytopenia (Thrombopenia) 10/2019 - 08/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2019 - 01/2016
2	Anemia 10/2019 - 10/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2013
2	Bacterial Infections (Bacterial Infection) 11/2017 - 02/2015
2	Sclerosis 01/2017 - 07/2012
2	Hypertension (High Blood Pressure) 01/2017 - 07/2012
2	Nephritis 01/2017 - 12/2001

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 11/2020 - 06/2008
16	Cisplatin (Platino)FDA LinkGeneric 10/2019 - 01/2002
16	Lipocalin-2IBA 11/2017 - 12/2004
9	CreatinineIBA 02/2019 - 11/2002
8	Biomarkers (Surrogate Marker)IBA 04/2018 - 04/2005
6	IronIBA 01/2022 - 03/2005
6	Carboplatin (JM8)FDA LinkGeneric 05/2020 - 07/2006
6	Gemcitabine FDA Link 10/2019 - 07/2007
5	Connective Tissue Growth FactorIBA 01/2018 - 05/2002
5	Irinotecan (Camptosar)FDA LinkGeneric 08/2016 - 01/2002
5	Paclitaxel (Taxol)FDA LinkGeneric 06/2012 - 12/2004
5	Transforming Growth Factor beta (TGF-beta)IBA 07/2009 - 12/2001
4	Pharmaceutical PreparationsIBA 02/2022 - 01/2011
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2007
4	AlbuminsIBA 01/2017 - 12/2013
4	Vinorelbine (Navelbine)FDA LinkGeneric 01/2013 - 03/2002
4	Docetaxel (Taxotere)FDA Link 11/2009 - 11/2002
3	Histones (Histone)IBA 01/2022 - 03/2011
3	Toll-Like Receptor 4IBA 01/2020 - 01/2014
3	Hormones (Hormone)IBA 10/2019 - 01/2005
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 10/2006
3	Etoposide (VP 16)FDA LinkGeneric 08/2016 - 01/2002
3	PlatinumIBA 01/2011 - 10/2006
3	Pemetrexed (MTA)FDA Link 11/2009 - 12/2004
3	SiderophoresIBA 07/2009 - 03/2005
2	LDL Lipoproteins (beta Lipoproteins)IBA 02/2022 - 04/2014
2	AnthracyclinesIBA 01/2022 - 10/2006
2	Atrial Natriuretic Factor (ANF)IBA 11/2021 - 02/2019
2	Serum AlbuminIBA 10/2021 - 01/2015
2	ErbB Receptors (EGF Receptor)IBA 05/2021 - 02/2010
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	pembrolizumabIBA 01/2021 - 01/2021
2	LigandsIBA 01/2020 - 01/2014
2	Bevacizumab (Avastin)FDA Link 11/2019 - 06/2012
2	human ERBB2 proteinIBA 10/2019 - 01/2018
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2019 - 12/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2019 - 03/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 01/2017
2	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 01/2018 - 01/2012
2	SodiumIBA 01/2018 - 01/2011
2	Carrier Proteins (Binding Protein)IBA 11/2017 - 07/2009
2	Oxygen (Dioxygen)IBA 11/2017 - 01/2013
2	SaltsIBA 01/2017 - 07/2012
2	FR 167653IBA 01/2017 - 09/2005
2	p38 Mitogen-Activated Protein KinasesIBA 01/2017 - 09/2005
2	AldosteroneIBA 01/2017 - 07/2012

Therapy/Procedure

20	Drug Therapy (Chemotherapy) 03/2022 - 02/2002
14	Therapeutics 05/2021 - 03/2002
8	Radiotherapy 03/2022 - 02/2002
5	Chemoradiotherapy 11/2016 - 10/2006
3	Renal Dialysis (Hemodialysis) 10/2022 - 01/2015
3	Combination Drug Therapy (Combination Chemotherapy) 08/2016 - 02/2004
2	Hepatectomy 02/2022 - 12/2016
2	Injections 01/2022 - 09/2009